Christian Bernard

Efficacy and Safety of Rasburicase (recombinant urate oxidase) for the Prevention and Treatment of Hyperuricemia During Induction Chemotherapy of Aggressive Non-Hodgkin’s Lymphoma: Results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) Study

Bertrand Coiffier, Nicolas Mounier, Serge Bologna et al. · Journal of Clinical Oncology · 2003 · 240 citations

Medicine, Pharmacology, Pharmacotherapy +14

Tumor necrosis factor α release is a major biological event associated with rituximab treatment

Jacques Bienvenu, Roland Chvetzoff, Gilles Salles et al. · The Hematology Journal · 2001 · 98 citations

Pharmacy, Immunology, Pharmacotherapy +16

Tolerability of HIV postexposure prophylaxis with tenofovir/emtricitabine and lopinavir/ritonavir tablet formulation

W. Tosini, Philippe Müller, Thiérry Prazuck et al. · AIDS · 2010 · 56 citations

Pharmacy, Infectious Diseases, Pharmacology +16

Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial

José Thomas, Christophe Fermé, Evert M. Noordijk et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 31 citations · Full text

Medicine, Oncology, Radiation Oncology +9

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Rémi Letestu, Abdelmalek Dahmani, Marouane Boubaya et al. · Leukemia · 2020 · 26 citations · Full text

Medicine, Clinical Sciences, Oncology +17